40862-12-2

Usage

Uses

Used in Pharmaceutical Industry:
Cyclopentanecarboxylic acid, 1-cyano-, methyl ester (9CI) is used as an intermediate in the synthesis of pharmaceutical compounds for various therapeutic applications. Its unique chemical structure allows for the development of new drugs with potential benefits in treating different medical conditions.
Used in Agrochemical Industry:
In the agrochemical industry, Cyclopentanecarboxylic acid, 1-cyano-, methyl ester (9CI) is used as a building block for the development of new agrochemicals, such as pesticides and herbicides. Its properties can contribute to the creation of more effective and environmentally friendly products for agricultural use.
Used in Organic Synthesis:
Cyclopentanecarboxylic acid, 1-cyano-, methyl ester (9CI) is utilized as a key component in the synthesis of other organic compounds. Its versatility in chemical reactions enables the production of a wide range of molecules with diverse applications in various fields, including materials science, chemical research, and specialty chemicals.

InChI:InChI=1/C8H11NO2/c1-11-7(10)8(6-9)4-2-3-5-8/h2-5H2,1H3

Upstream product

• 62168-25-6 1,1-dibromobutane 
• 105-34-0 methyl 2-cyanoacetate 
• 110-52-1 1,4-dibromo-butane 
• 584-08-7 potassium carbonate 

Downstream Products

• 186375-13-3 1-[(S)-Cyano-((S)-1-phenyl-ethylamino)-methyl]-cyclopentanecarboxylic acid methyl ester 
• 186375-14-4 1-[(S)-Carbamoyl-((S)-1-phenyl-ethylamino)-methyl]-cyclopentanecarboxylic acid methyl ester 
• 99092-03-2 methyl 1-(aminomethyl)cyclopentanecarboxylate 
• 204514-22-7 1-(<<(tert-butoxy)carbonyl>amino>methyl)cyclopentane-1-carboxylic acid 
• 102074-43-1 1-(aminomethyl)cyclopentane carboxylic acid 

Relevant academic research and scientific papers

Substituted cycloalkyls as inhibitors of a beta protein production

This invention relates to novel lactams having the Formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease and Down's Syndrome.

Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid

Disclosed herein is a process for preparing (S)-α-amino-1-carboxycyclopentaneacetic acid which is a useful intermediate for preparing peptidomimetic inhibitors of herpes viral ribonucleotide reductase. The process comprises the preparation of the key intermediate STR1 and its subsequent conversion to the desired product.

An enantioselective synthesis of cyclopentyl-l-aspartic acid amenable to large scale

A new enantioselective synthesis of cyclopentyl-L-aspartic acid [(S)α-amino-1-(carboxy)cyclopentaneacetic acid] (1) and its N-Boc derivative 2 has been developed. This synthesis is amenable to kilogram scale preparation and avoids low temperature reactions and column chromatography.